Previous close | 1.1950 |
Open | 1.2200 |
Bid | 1.1900 x 100 |
Ask | 1.2500 x 900 |
Day's range | 1.1800 - 1.2400 |
52-week range | 0.5720 - 2.5750 |
Volume | |
Avg. volume | 2,342,109 |
Market cap | 201.526M |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Institutions' substantial holdings in X4 Pharmaceuticals implies that they have significant influence over...
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript March 21, 2024 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.15. XFOR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. And welcome to the X4 […]
Q4 2023 X4 Pharmaceuticals Inc Earnings Call